Evidence map›Paper›PMID 35746638›Full record

ReviewViruses2022

γδ T Cells in Emerging Viral Infection: An Overview.

Eleonora Cimini, Chiara Agrati

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Deep insight into cytokine storm: from pathogenesis to treatment.Signal transduction and targeted therapy · 2025
    Review
  5. Article
  6. Review
  7. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eleonora CiminiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, "L. Spallanzani", Via Portuense 292, 00149 Rome, Italy.
Chiara AgratiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, "L. Spallanzani", Via Portuense 292, 00149 Rome, Italy.ORCID 0000-0002-5252-0927
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New emerging viruses belonging to the

Indexed as

COVID-19SARS-CoV-2Antiviral AgentsHumansImmunity, InnatePandemicsAntiviral Agentsantiviral activitycoronavirusesfilovirusesflavivirusesgammadelta T cellsinnate immunity

Identifiers

PMID35746638
PMCPMC9230790
OpenAlexW4281872727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.